It is specifically designed for patients with chronic myelogenous leukemia (CML) who have an enzyme called BCR-ABL tyrosine kinase, produced by a cytogenetic abnormality known as the Philadelphia chromosome. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.